Quang X. Pham, CEO and Chairman, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 652 shares at $5.01 ($3K) on 2026-05-29, disclosed to the SEC on 2026-06-02.
Scheduled sale ($3k) by CEO and Chairman, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.01 | 303 | $2K | 49.4% |
| 2 | $4.46 | 349 | $2K | 50.6% |
| Total | $4.72 avg | 652 | $3K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |